Changing Life Sciences Value Chain

Archives for February 2014 « Recent Articles

Photo of Eric NewmarkOffline

As major compliance deadlines come and go in the pharma sales and marketing world, organizations are now finally able to turn their focus to optimizing everything that's changed in recent years, both process and IT-wise.

Photo of Dr. Alan S. LouieOffline

The move to eliminate excess capacity and externalize non-core competencies has driven leading life science companies towards process-centric approaches that have the strong potential to stifle creativity and encourage incrementalism. With most organizational initiatives requiring near term ROI to justify investment, there is little room for paradigm changing innovations. With the exception of sheer luck allowing organizations to capture new drug or market opportunities through M&A, there remains a need to encourage innovation even in operationally efficient organizations.

Viewed 759,814 times